Search
Print Page   |   Contact Us   |   Sign In   |   Join Today
News & Press: Company News

Kaleo Partnering With Clinton Foundation On Evzio

Tuesday, January 27, 2015  
Share |
Kaleo has partnered with the Clinton Foundation to provide colleges, universities and public safety organizations with bulk discounts for its medical device for emergency treatment of opioid overdoses, EVZIO® naloxone auto-injector.

Kaleo's chief executive officer, Spencer Williamson made the announcement from center stage during the Foundation's Health Matters Activation Summit in Palm. The summit brought together leaders in healthcare, public policy, veterans affairs, business, education, and professional sports to identify and implement strategies for systemic health improvement.

The Clinton Foundation, established by former U.S. President Bill Clinton, supports health programs. The foundation’s Clinton Health Matters Initiative (CHMI) has chosen to make prevention of opioid overdoses its major initiative for 2015 and will work to promote the Evzio device. The agreement is a part of CHMI’s efforts to ensure that there is a predictable and affordable supply of Naloxone, a life-saving opioid suppressant that can reverse opioid caused overdoses.

Evzio, approved by the Food and Drug Administration in 2014, is a hand-held device about the size of a credit card that provides a dose of naloxone to treat the effects of an opioid overdose. The device is designed to be used by family members or others in a nonmedical setting such as in a dormitory or home, providing time for emergency responders to arrive.

“We think this is really exciting in a way that we hope will continue to bring about awareness of this public health epidemic in the U.S.,” said Williamson. “There are over 16,000 deaths that occur annually from prescription opioids,” such as painkillers, Williamson continued.

Former President Bill Clinton described the initiative as "something which I think will save a lot of lives."

Rain Henderson, CEO of the Clinton Foundation said during the announcement. “That makes it very hard for community groups, organizations [and] policymakers to plan for how to purchase Evzio. The manufacturing landscape has been changing quite dramatically, and the pricing and the availability of naloxone has been unpredictable,”

“For us, the point was to create a predictable and affordable supply," she went on, "so you could have more organizations purchasing Naloxone and using a device like the Evzio auto-injector to save people’s lives."

According to Williamson about 75 universities already have expressed interest in having the Evzio device available on their campuses.

more Events

12/12/2016 » 12/14/2016
ISBioTech 4th Fall Meeting

12/14/2016
Webinar; Investor Tax Credits

Premium Members

Membership Software Powered by YourMembership  ::  Legal